ssha@usana.com   Visit Our USANA Website£ºwww.healthnutritionals.com.au
Phone: 61 7 3423 7237   61 4 10629309
Home Vitamins and Minerals Diet and Energy Sense Skin Care True Health Assessment About us Shop Online Blog
  Blog
Blog
Proglucamune
Proglucamune¡­
Price:   $82.5
Code:   
HepaPlus TM
HepaPlus&nbs¡­
Price:   $52.8
Code:   135
BiOmegaTM Jr.
BiOmegaTM&nb¡­
Price:   $16.5
Code:   144
Your present location: Home >> Blog  
 
High vitamin D levels improve survival in patients w/ colorectal & breast cancer
Date£º[21/04/2014 11:18:45 AM]   All[1066]Time

 

Beast cancer (BC) and colorectal cancer (CRC) are two of the most common causes of cancer death worldwide. These cancers share many of the same risk factors which include smoking, physical inactivity, poor diet, excessive alcohol consumption and obesity. The results of several studies have suggested that low vitamin D levels may be a potential risk factor for many cancers, including BC and CRC.
In a recent study published in the European Journal of Cancer, researchers summarized the evidence regarding a potential protective role of high Vitamin D levels with cancer mortality, and specifically among BC and CRC patients.
 
The comprehensive literature search included studies which analyzed the association of vitamin D with survival in breast cancer and colorectal cancer patients. The review included five studies of colorectal cancer patients (n=2,330), and five studies of breast cancer patients (n=4,413). The studies all compared mortality across two to five categories of vitamin D levels.
 
Among colorectal cancer patients, when compared to the category of lowest vitamin D, the group with the highest vitamin D levels had a 29% decreased risk of overall cancer mortality, and a 35% decreased mortality risk of CRC specifically. Comparing high to low vitamin D levels among breast cancer patients revealed a 38% and 42% reduction of overall cancer and BC mortality respectively.
 
Higher Vitamin D levels (>75nmol/L or 30 ng/dl) were associated with significantly reduced mortality in patients with colorectal and breast cancer. Our results have potential implications for vitamin D deficient patients for whom enhancement of their vitamin D status could improve their survival.
Maalmi H. et al., Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studies. Eur J Cancer (2014).
 
Previous £ºSupplement Spotlight: Bring on the BiOmega Fish Oil 
Next£ºAustralian infants under two years of age have excessive salt intake
 
  Some of the images on this site are owned by USANA Health Sciences and have been reproduced with their permission
 
   
  SS International Group Pty Ltd is a proprietary company registered in Australia. SS International Group is proud of bein¡­   [Details]   T: 61 7 3423 7237
M: 61 4 10629309
E: ssha@usana.com
  Copyright£ºSS International Group Pty. Ltd.    Technical support£ºShenghao network    www.ssha.usana.com